Skip to main content
Premium Trial:

Request an Annual Quote

Tabula Rasa Healthcare, OneOme Form Precision Prescribing Alliance

NEW YORK — Tabula Rasa HealthCare said on Thursday that it has signed an agreement to combine its MedWise medication decision support software with OneOme's RightMed pharmacogenomics test.

Financial and other terms of the deal were not disclosed.

MedWise reviews a patient's medication regimen in order to identify accumulative multi-drug interactions and support treatment decision-making. RightMed analyzes 27 genes in order to predict how a patient will respond to a particular drug.

"The additive power of combining OneOme's RightMed Test with … MedWise technology will bring more precision pharmacotherapy opportunities to our partners in programs of all-inclusive care for the elderly organizations and beyond," Tabula Rasa Chairman and CEO Calvin Knowlton said in a statement.

In mid-2019, Moorestown, New Jersey-based Tabula Rasa formed a pharmacogenomics delivery and analytics alliance with CQuentia. The previous year, Minneapolis-based OneOme received approval from the New York State Department of Health for RightMed.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.